31-Oct-2026 15:28:00

ADVENZYMES Q2 : CONS NET PROFIT UP 14% AT ₹51.2 CR (YOY), UP 33% (QOQ). GOOD (On 1st Look)

Revenue up 16% at ₹214.5 Cr (YOY), up 12% (QOQ). Ebitda up 20% at ₹72.1 Cr (YOY), up 36% (QOQ); margins 34% v 33% (YOY), 28% (QOQ). Human Nutrition up 6%, Animal Nutrition up 37%, Bio-Processing up 43% (YOY).

Advanced Enzyme Technologies Limited

← Back to feed